This is a federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSequence Testing Services to the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price pricing type, with a total ceiling value of $120,000.00 and a period of performance through February 12, 2028. This award is not set aside and is likely part of a larger Indefinite Delivery/Indefinite Quantity (ID/IQ) contract or Blanket Purchase Agreement (BPA) that Cytopath Biopsy Lab Inc. holds with the VA to provide specialized thyroid cancer diagnostic testing services, including ThyroSeq genetic mutation analysis, to support cancer screening and diagnosis programs for veterans. Similar ThyroSeq testing services have also been provided to the Defense Health Agency and Walter Reed National Military Medical Center to address the needs of the active military and veteran populations within the defense health system.
Generated 1/28/25, 12:22 PM